Correlation between copy number variations of arm-level result and selected clinical features
Brain Lower Grade Glioma (Primary solid tumor)
16 April 2014  |  analyses__2014_04_16
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between copy number variations of arm-level result and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C1VT1QR1
Overview
Introduction

This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.

Summary

Testing the association between copy number variation 78 arm-level events and 6 clinical features across 359 patients, 25 significant findings detected with Q value < 0.25.

  • 1q gain cnv correlated to 'AGE'.

  • 3q gain cnv correlated to 'Time to Death'.

  • 7p gain cnv correlated to 'Time to Death' and 'AGE'.

  • 7q gain cnv correlated to 'Time to Death' and 'AGE'.

  • 10p gain cnv correlated to 'RADIATIONS.RADIATION.REGIMENINDICATION'.

  • 19p gain cnv correlated to 'HISTOLOGICAL.TYPE'.

  • 19q gain cnv correlated to 'Time to Death' and 'AGE'.

  • 20p gain cnv correlated to 'Time to Death' and 'AGE'.

  • 20q gain cnv correlated to 'Time to Death' and 'AGE'.

  • 1p loss cnv correlated to 'HISTOLOGICAL.TYPE'.

  • 6q loss cnv correlated to 'HISTOLOGICAL.TYPE'.

  • 9p loss cnv correlated to 'Time to Death'.

  • 10p loss cnv correlated to 'Time to Death',  'AGE', and 'HISTOLOGICAL.TYPE'.

  • 10q loss cnv correlated to 'Time to Death',  'AGE', and 'HISTOLOGICAL.TYPE'.

  • 14q loss cnv correlated to 'Time to Death'.

  • 19q loss cnv correlated to 'HISTOLOGICAL.TYPE'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 78 arm-level events and 6 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 25 significant findings detected.

Clinical
Features
Time
to
Death
AGE GENDER KARNOFSKY
PERFORMANCE
SCORE
HISTOLOGICAL
TYPE
RADIATIONS
RADIATION
REGIMENINDICATION
nCNV (%) nWild-Type logrank test t-test Fisher's exact test t-test Fisher's exact test Fisher's exact test
10p loss 58 (16%) 301 0
(0)
7.19e-13
(3.31e-10)
0.25
(1.00)
0.00494
(1.00)
0.000346
(0.153)
0.508
(1.00)
10q loss 68 (19%) 291 1.25e-10
(5.71e-08)
1.99e-11
(9.13e-09)
0.225
(1.00)
0.0118
(1.00)
0.000157
(0.0699)
0.641
(1.00)
7p gain 85 (24%) 274 8.75e-05
(0.0392)
3.04e-06
(0.00138)
0.262
(1.00)
0.0209
(1.00)
0.107
(1.00)
0.393
(1.00)
7q gain 110 (31%) 249 0.000146
(0.0653)
5.01e-07
(0.000229)
0.358
(1.00)
0.138
(1.00)
0.0897
(1.00)
0.691
(1.00)
19q gain 18 (5%) 341 8.46e-06
(0.00383)
7.23e-05
(0.0325)
0.631
(1.00)
0.493
(1.00)
0.314
(1.00)
0.781
(1.00)
20p gain 34 (9%) 325 7.49e-07
(0.000341)
2.78e-06
(0.00126)
0.47
(1.00)
0.145
(1.00)
0.125
(1.00)
0.678
(1.00)
20q gain 35 (10%) 324 6.88e-07
(0.000314)
1.71e-05
(0.0077)
0.211
(1.00)
0.216
(1.00)
0.183
(1.00)
0.68
(1.00)
1q gain 15 (4%) 344 0.352
(1.00)
0.000432
(0.191)
0.117
(1.00)
0.263
(1.00)
0.266
(1.00)
0.54
(1.00)
3q gain 8 (2%) 351 0.000463
(0.204)
0.0543
(1.00)
0.478
(1.00)
0.383
(1.00)
0.0436
(1.00)
0.415
(1.00)
10p gain 33 (9%) 326 0.67
(1.00)
0.00479
(1.00)
0.0675
(1.00)
0.105
(1.00)
0.0111
(1.00)
0.00051
(0.224)
19p gain 69 (19%) 290 0.385
(1.00)
0.00588
(1.00)
0.503
(1.00)
0.111
(1.00)
6.21e-05
(0.0279)
0.877
(1.00)
1p loss 132 (37%) 227 0.00981
(1.00)
0.002
(0.856)
1
(1.00)
0.891
(1.00)
7.27e-30
(3.36e-27)
0.0158
(1.00)
6q loss 41 (11%) 318 0.000846
(0.37)
0.058
(1.00)
0.741
(1.00)
0.15
(1.00)
0.000565
(0.248)
0.0823
(1.00)
9p loss 78 (22%) 281 9.13e-05
(0.0408)
0.144
(1.00)
0.369
(1.00)
0.531
(1.00)
0.0434
(1.00)
0.0267
(1.00)
14q loss 55 (15%) 304 0.0002
(0.0888)
0.000788
(0.345)
0.66
(1.00)
0.102
(1.00)
0.221
(1.00)
0.403
(1.00)
19q loss 149 (42%) 210 0.136
(1.00)
0.0548
(1.00)
1
(1.00)
0.813
(1.00)
1.51e-26
(6.98e-24)
0.172
(1.00)
1p gain 10 (3%) 349 0.00287
(1.00)
0.0273
(1.00)
0.197
(1.00)
0.0205
(1.00)
0.00501
(1.00)
0.714
(1.00)
2p gain 7 (2%) 352 0.556
(1.00)
0.0732
(1.00)
0.707
(1.00)
0.479
(1.00)
0.504
(1.00)
0.685
(1.00)
2q gain 6 (2%) 353 0.909
(1.00)
0.155
(1.00)
0.42
(1.00)
0.479
(1.00)
0.292
(1.00)
0.64
(1.00)
3p gain 10 (3%) 349 0.00132
(0.575)
0.102
(1.00)
0.523
(1.00)
0.903
(1.00)
0.0312
(1.00)
0.714
(1.00)
4p gain 8 (2%) 351 0.289
(1.00)
0.953
(1.00)
0.297
(1.00)
0.709
(1.00)
0.0436
(1.00)
0.685
(1.00)
4q gain 3 (1%) 356 0.648
(1.00)
0.612
(1.00)
1
(1.00)
0.632
(1.00)
1
(1.00)
5p gain 7 (2%) 352 0.502
(1.00)
0.249
(1.00)
1
(1.00)
0.466
(1.00)
0.345
(1.00)
1
(1.00)
5q gain 5 (1%) 354 0.831
(1.00)
0.446
(1.00)
0.665
(1.00)
0.158
(1.00)
0.636
(1.00)
0.338
(1.00)
6p gain 6 (2%) 353 0.755
(1.00)
0.167
(1.00)
0.0982
(1.00)
0.0205
(1.00)
0.292
(1.00)
0.64
(1.00)
8p gain 31 (9%) 328 0.549
(1.00)
0.88
(1.00)
0.454
(1.00)
0.198
(1.00)
0.0812
(1.00)
1
(1.00)
8q gain 38 (11%) 321 0.509
(1.00)
0.326
(1.00)
0.492
(1.00)
0.0658
(1.00)
0.00344
(1.00)
0.843
(1.00)
9p gain 14 (4%) 345 0.0537
(1.00)
0.0291
(1.00)
0.0592
(1.00)
0.727
(1.00)
0.332
(1.00)
1
(1.00)
9q gain 19 (5%) 340 0.0356
(1.00)
0.0227
(1.00)
0.0168
(1.00)
0.725
(1.00)
0.0986
(1.00)
0.426
(1.00)
10q gain 5 (1%) 354 0.712
(1.00)
0.339
(1.00)
0.0648
(1.00)
0.103
(1.00)
0.0998
(1.00)
11p gain 25 (7%) 334 0.555
(1.00)
0.064
(1.00)
0.152
(1.00)
0.565
(1.00)
0.114
(1.00)
1
(1.00)
11q gain 41 (11%) 318 0.745
(1.00)
0.0668
(1.00)
0.0462
(1.00)
0.839
(1.00)
0.541
(1.00)
1
(1.00)
12p gain 26 (7%) 333 0.819
(1.00)
0.734
(1.00)
0.152
(1.00)
0.589
(1.00)
0.714
(1.00)
1
(1.00)
12q gain 12 (3%) 347 0.00159
(0.684)
0.248
(1.00)
0.155
(1.00)
0.514
(1.00)
1
(1.00)
0.737
(1.00)
13q gain 3 (1%) 356 0.529
(1.00)
0.818
(1.00)
0.596
(1.00)
0.468
(1.00)
0.28
(1.00)
1
(1.00)
14q gain 3 (1%) 356 0.469
(1.00)
0.391
(1.00)
1
(1.00)
1
(1.00)
0.153
(1.00)
15q gain 7 (2%) 352 0.103
(1.00)
0.00588
(1.00)
0.459
(1.00)
0.681
(1.00)
0.345
(1.00)
0.685
(1.00)
16p gain 13 (4%) 346 0.314
(1.00)
0.064
(1.00)
0.272
(1.00)
0.858
(1.00)
0.131
(1.00)
0.743
(1.00)
16q gain 13 (4%) 346 0.113
(1.00)
0.327
(1.00)
0.272
(1.00)
0.389
(1.00)
0.0351
(1.00)
0.323
(1.00)
17p gain 15 (4%) 344 0.041
(1.00)
0.284
(1.00)
0.429
(1.00)
0.169
(1.00)
0.0625
(1.00)
0.77
(1.00)
17q gain 16 (4%) 343 0.00554
(1.00)
0.318
(1.00)
0.307
(1.00)
0.86
(1.00)
0.181
(1.00)
1
(1.00)
18p gain 11 (3%) 348 0.0638
(1.00)
0.696
(1.00)
1
(1.00)
0.615
(1.00)
0.435
(1.00)
1
(1.00)
18q gain 8 (2%) 351 0.142
(1.00)
0.719
(1.00)
0.731
(1.00)
0.158
(1.00)
0.608
(1.00)
0.685
(1.00)
21q gain 20 (6%) 339 0.175
(1.00)
0.0168
(1.00)
0.819
(1.00)
0.276
(1.00)
0.476
(1.00)
1
(1.00)
22q gain 11 (3%) 348 0.949
(1.00)
0.115
(1.00)
0.76
(1.00)
0.978
(1.00)
0.0822
(1.00)
0.737
(1.00)
xq gain 27 (8%) 332 0.905
(1.00)
0.507
(1.00)
0.00911
(1.00)
0.666
(1.00)
0.187
(1.00)
0.643
(1.00)
1q loss 19 (5%) 340 0.92
(1.00)
0.0388
(1.00)
0.639
(1.00)
0.1
(1.00)
0.239
(1.00)
0.584
(1.00)
2p loss 13 (4%) 346 0.178
(1.00)
0.758
(1.00)
0.154
(1.00)
0.765
(1.00)
0.458
(1.00)
1
(1.00)
2q loss 13 (4%) 346 0.848
(1.00)
0.111
(1.00)
0.396
(1.00)
0.727
(1.00)
0.105
(1.00)
1
(1.00)
3p loss 15 (4%) 344 0.00894
(1.00)
0.659
(1.00)
0.429
(1.00)
0.0227
(1.00)
0.635
(1.00)
0.77
(1.00)
3q loss 20 (6%) 339 0.0139
(1.00)
0.87
(1.00)
0.065
(1.00)
0.241
(1.00)
0.878
(1.00)
0.597
(1.00)
4p loss 52 (14%) 307 0.891
(1.00)
0.00148
(0.641)
0.176
(1.00)
0.559
(1.00)
0.00169
(0.728)
0.489
(1.00)
4q loss 67 (19%) 292 0.882
(1.00)
0.174
(1.00)
0.222
(1.00)
0.631
(1.00)
0.0123
(1.00)
0.438
(1.00)
5p loss 27 (8%) 332 0.388
(1.00)
0.0887
(1.00)
1
(1.00)
0.238
(1.00)
0.0228
(1.00)
0.0199
(1.00)
5q loss 26 (7%) 333 0.0835
(1.00)
0.341
(1.00)
0.421
(1.00)
0.719
(1.00)
0.0901
(1.00)
0.0557
(1.00)
6p loss 22 (6%) 337 0.00091
(0.397)
0.388
(1.00)
0.665
(1.00)
0.344
(1.00)
0.0506
(1.00)
1
(1.00)
7p loss 3 (1%) 356 0.486
(1.00)
0.528
(1.00)
0.596
(1.00)
0.632
(1.00)
1
(1.00)
7q loss 3 (1%) 356 0.655
(1.00)
0.86
(1.00)
1
(1.00)
0.897
(1.00)
0.632
(1.00)
1
(1.00)
8p loss 12 (3%) 347 0.0444
(1.00)
0.151
(1.00)
1
(1.00)
0.543
(1.00)
0.262
(1.00)
0.501
(1.00)
8q loss 9 (3%) 350 0.0123
(1.00)
0.223
(1.00)
0.738
(1.00)
0.482
(1.00)
0.398
(1.00)
1
(1.00)
9q loss 31 (9%) 328 0.00515
(1.00)
0.234
(1.00)
0.708
(1.00)
0.0545
(1.00)
0.794
(1.00)
0.831
(1.00)
11p loss 45 (13%) 314 0.313
(1.00)
0.214
(1.00)
0.201
(1.00)
0.995
(1.00)
0.0578
(1.00)
0.467
(1.00)
11q loss 16 (4%) 343 0.0113
(1.00)
0.073
(1.00)
0.801
(1.00)
0.135
(1.00)
0.0803
(1.00)
0.376
(1.00)
12p loss 15 (4%) 344 0.8
(1.00)
0.229
(1.00)
0.604
(1.00)
0.941
(1.00)
0.334
(1.00)
0.54
(1.00)
12q loss 31 (9%) 328 0.921
(1.00)
0.362
(1.00)
0.574
(1.00)
0.564
(1.00)
0.0679
(1.00)
0.383
(1.00)
13q loss 84 (23%) 275 0.251
(1.00)
0.685
(1.00)
0.171
(1.00)
0.293
(1.00)
0.687
(1.00)
0.0213
(1.00)
15q loss 32 (9%) 327 0.2
(1.00)
0.474
(1.00)
0.854
(1.00)
0.714
(1.00)
0.466
(1.00)
1
(1.00)
16p loss 9 (3%) 350 0.21
(1.00)
0.00397
(1.00)
0.515
(1.00)
0.0772
(1.00)
0.836
(1.00)
1
(1.00)
16q loss 16 (4%) 343 0.148
(1.00)
0.00486
(1.00)
0.801
(1.00)
0.892
(1.00)
0.769
(1.00)
0.557
(1.00)
17p loss 12 (3%) 347 0.0163
(1.00)
0.0357
(1.00)
0.238
(1.00)
0.025
(1.00)
0.534
(1.00)
0.307
(1.00)
17q loss 8 (2%) 351 0.415
(1.00)
0.11
(1.00)
0.478
(1.00)
0.156
(1.00)
0.674
(1.00)
0.685
(1.00)
18p loss 51 (14%) 308 0.704
(1.00)
0.0313
(1.00)
0.033
(1.00)
0.666
(1.00)
0.402
(1.00)
0.726
(1.00)
18q loss 47 (13%) 312 0.797
(1.00)
0.0788
(1.00)
0.161
(1.00)
0.74
(1.00)
0.312
(1.00)
1
(1.00)
19p loss 18 (5%) 341 0.341
(1.00)
0.62
(1.00)
0.81
(1.00)
0.561
(1.00)
0.911
(1.00)
0.166
(1.00)
20p loss 3 (1%) 356 0.511
(1.00)
0.486
(1.00)
0.596
(1.00)
1
(1.00)
0.576
(1.00)
21q loss 20 (6%) 339 0.662
(1.00)
0.61
(1.00)
0.249
(1.00)
0.0804
(1.00)
0.101
(1.00)
0.792
(1.00)
22q loss 39 (11%) 320 0.00136
(0.59)
0.00142
(0.614)
0.5
(1.00)
0.00792
(1.00)
0.168
(1.00)
1
(1.00)
xq loss 47 (13%) 312 0.0451
(1.00)
0.23
(1.00)
0.641
(1.00)
0.487
(1.00)
0.461
(1.00)
0.858
(1.00)
'1q gain' versus 'AGE'

P value = 0.000432 (t-test), Q value = 0.19

Table S1.  Gene #2: '1q gain' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
1Q GAIN MUTATED 15 55.8 (10.8)
1Q GAIN WILD-TYPE 344 43.1 (13.4)

Figure S1.  Get High-res Image Gene #2: '1q gain' versus Clinical Feature #2: 'AGE'

'3q gain' versus 'Time to Death'

P value = 0.000463 (logrank test), Q value = 0.2

Table S2.  Gene #6: '3q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
3Q GAIN MUTATED 8 4 0.2 - 47.8 (9.1)
3Q GAIN WILD-TYPE 348 64 0.0 - 211.2 (14.9)

Figure S2.  Get High-res Image Gene #6: '3q gain' versus Clinical Feature #1: 'Time to Death'

'7p gain' versus 'Time to Death'

P value = 8.75e-05 (logrank test), Q value = 0.039

Table S3.  Gene #12: '7p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
7P GAIN MUTATED 85 30 0.1 - 211.2 (13.7)
7P GAIN WILD-TYPE 271 38 0.0 - 182.3 (15.0)

Figure S3.  Get High-res Image Gene #12: '7p gain' versus Clinical Feature #1: 'Time to Death'

'7p gain' versus 'AGE'

P value = 3.04e-06 (t-test), Q value = 0.0014

Table S4.  Gene #12: '7p gain' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
7P GAIN MUTATED 85 49.7 (13.3)
7P GAIN WILD-TYPE 274 41.7 (13.0)

Figure S4.  Get High-res Image Gene #12: '7p gain' versus Clinical Feature #2: 'AGE'

'7q gain' versus 'Time to Death'

P value = 0.000146 (logrank test), Q value = 0.065

Table S5.  Gene #13: '7q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
7Q GAIN MUTATED 108 35 0.1 - 211.2 (15.0)
7Q GAIN WILD-TYPE 248 33 0.0 - 182.3 (14.8)

Figure S5.  Get High-res Image Gene #13: '7q gain' versus Clinical Feature #1: 'Time to Death'

'7q gain' versus 'AGE'

P value = 5.01e-07 (t-test), Q value = 0.00023

Table S6.  Gene #13: '7q gain' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
7Q GAIN MUTATED 110 49.1 (13.5)
7Q GAIN WILD-TYPE 249 41.2 (12.8)

Figure S6.  Get High-res Image Gene #13: '7q gain' versus Clinical Feature #2: 'AGE'

'10p gain' versus 'RADIATIONS.RADIATION.REGIMENINDICATION'

P value = 0.00051 (Fisher's exact test), Q value = 0.22

Table S7.  Gene #18: '10p gain' versus Clinical Feature #6: 'RADIATIONS.RADIATION.REGIMENINDICATION'

nPatients NO YES
ALL 89 270
10P GAIN MUTATED 17 16
10P GAIN WILD-TYPE 72 254

Figure S7.  Get High-res Image Gene #18: '10p gain' versus Clinical Feature #6: 'RADIATIONS.RADIATION.REGIMENINDICATION'

'19p gain' versus 'HISTOLOGICAL.TYPE'

P value = 6.21e-05 (Fisher's exact test), Q value = 0.028

Table S8.  Gene #33: '19p gain' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 123 99 137
19P GAIN MUTATED 12 15 42
19P GAIN WILD-TYPE 111 84 95

Figure S8.  Get High-res Image Gene #33: '19p gain' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'19q gain' versus 'Time to Death'

P value = 8.46e-06 (logrank test), Q value = 0.0038

Table S9.  Gene #34: '19q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
19Q GAIN MUTATED 18 7 0.5 - 49.5 (11.8)
19Q GAIN WILD-TYPE 338 61 0.0 - 211.2 (15.0)

Figure S9.  Get High-res Image Gene #34: '19q gain' versus Clinical Feature #1: 'Time to Death'

'19q gain' versus 'AGE'

P value = 7.23e-05 (t-test), Q value = 0.032

Table S10.  Gene #34: '19q gain' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
19Q GAIN MUTATED 18 56.3 (10.9)
19Q GAIN WILD-TYPE 341 42.9 (13.3)

Figure S10.  Get High-res Image Gene #34: '19q gain' versus Clinical Feature #2: 'AGE'

'20p gain' versus 'Time to Death'

P value = 7.49e-07 (logrank test), Q value = 0.00034

Table S11.  Gene #35: '20p gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
20P GAIN MUTATED 34 12 0.5 - 49.5 (11.8)
20P GAIN WILD-TYPE 322 56 0.0 - 211.2 (15.0)

Figure S11.  Get High-res Image Gene #35: '20p gain' versus Clinical Feature #1: 'Time to Death'

'20p gain' versus 'AGE'

P value = 2.78e-06 (t-test), Q value = 0.0013

Table S12.  Gene #35: '20p gain' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
20P GAIN MUTATED 34 54.9 (12.7)
20P GAIN WILD-TYPE 325 42.4 (13.0)

Figure S12.  Get High-res Image Gene #35: '20p gain' versus Clinical Feature #2: 'AGE'

'20q gain' versus 'Time to Death'

P value = 6.88e-07 (logrank test), Q value = 0.00031

Table S13.  Gene #36: '20q gain' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
20Q GAIN MUTATED 35 12 0.5 - 49.5 (12.2)
20Q GAIN WILD-TYPE 321 56 0.0 - 211.2 (15.0)

Figure S13.  Get High-res Image Gene #36: '20q gain' versus Clinical Feature #1: 'Time to Death'

'20q gain' versus 'AGE'

P value = 1.71e-05 (t-test), Q value = 0.0077

Table S14.  Gene #36: '20q gain' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
20Q GAIN MUTATED 35 54.1 (13.5)
20Q GAIN WILD-TYPE 324 42.5 (13.0)

Figure S14.  Get High-res Image Gene #36: '20q gain' versus Clinical Feature #2: 'AGE'

'1p loss' versus 'HISTOLOGICAL.TYPE'

P value = 7.27e-30 (Fisher's exact test), Q value = 3.4e-27

Table S15.  Gene #40: '1p loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 123 99 137
1P LOSS MUTATED 7 28 97
1P LOSS WILD-TYPE 116 71 40

Figure S15.  Get High-res Image Gene #40: '1p loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'6q loss' versus 'HISTOLOGICAL.TYPE'

P value = 0.000565 (Fisher's exact test), Q value = 0.25

Table S16.  Gene #51: '6q loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 123 99 137
6Q LOSS MUTATED 25 9 7
6Q LOSS WILD-TYPE 98 90 130

Figure S16.  Get High-res Image Gene #51: '6q loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'9p loss' versus 'Time to Death'

P value = 9.13e-05 (logrank test), Q value = 0.041

Table S17.  Gene #56: '9p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
9P LOSS MUTATED 78 25 0.1 - 117.4 (16.1)
9P LOSS WILD-TYPE 278 43 0.0 - 211.2 (14.5)

Figure S17.  Get High-res Image Gene #56: '9p loss' versus Clinical Feature #1: 'Time to Death'

'10p loss' versus 'Time to Death'

P value = 0 (logrank test), Q value = 0

Table S18.  Gene #58: '10p loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
10P LOSS MUTATED 58 28 0.1 - 134.3 (11.4)
10P LOSS WILD-TYPE 298 40 0.0 - 211.2 (15.3)

Figure S18.  Get High-res Image Gene #58: '10p loss' versus Clinical Feature #1: 'Time to Death'

'10p loss' versus 'AGE'

P value = 7.19e-13 (t-test), Q value = 3.3e-10

Table S19.  Gene #58: '10p loss' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
10P LOSS MUTATED 58 55.4 (11.4)
10P LOSS WILD-TYPE 301 41.3 (12.7)

Figure S19.  Get High-res Image Gene #58: '10p loss' versus Clinical Feature #2: 'AGE'

'10p loss' versus 'HISTOLOGICAL.TYPE'

P value = 0.000346 (Fisher's exact test), Q value = 0.15

Table S20.  Gene #58: '10p loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 123 99 137
10P LOSS MUTATED 33 13 12
10P LOSS WILD-TYPE 90 86 125

Figure S20.  Get High-res Image Gene #58: '10p loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'10q loss' versus 'Time to Death'

P value = 1.25e-10 (logrank test), Q value = 5.7e-08

Table S21.  Gene #59: '10q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
10Q LOSS MUTATED 67 32 0.1 - 156.2 (12.2)
10Q LOSS WILD-TYPE 289 36 0.0 - 211.2 (15.1)

Figure S21.  Get High-res Image Gene #59: '10q loss' versus Clinical Feature #1: 'Time to Death'

'10q loss' versus 'AGE'

P value = 1.99e-11 (t-test), Q value = 9.1e-09

Table S22.  Gene #59: '10q loss' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 359 43.6 (13.5)
10Q LOSS MUTATED 68 54.0 (12.6)
10Q LOSS WILD-TYPE 291 41.2 (12.5)

Figure S22.  Get High-res Image Gene #59: '10q loss' versus Clinical Feature #2: 'AGE'

'10q loss' versus 'HISTOLOGICAL.TYPE'

P value = 0.000157 (Fisher's exact test), Q value = 0.07

Table S23.  Gene #59: '10q loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 123 99 137
10Q LOSS MUTATED 38 15 15
10Q LOSS WILD-TYPE 85 84 122

Figure S23.  Get High-res Image Gene #59: '10q loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

'14q loss' versus 'Time to Death'

P value = 2e-04 (logrank test), Q value = 0.089

Table S24.  Gene #65: '14q loss' versus Clinical Feature #1: 'Time to Death'

nPatients nDeath Duration Range (Median), Month
ALL 356 68 0.0 - 211.2 (14.8)
14Q LOSS MUTATED 54 19 0.2 - 130.8 (15.0)
14Q LOSS WILD-TYPE 302 49 0.0 - 211.2 (14.7)

Figure S24.  Get High-res Image Gene #65: '14q loss' versus Clinical Feature #1: 'Time to Death'

'19q loss' versus 'HISTOLOGICAL.TYPE'

P value = 1.51e-26 (Fisher's exact test), Q value = 7e-24

Table S25.  Gene #74: '19q loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

nPatients ASTROCYTOMA OLIGOASTROCYTOMA OLIGODENDROGLIOMA
ALL 123 99 137
19Q LOSS MUTATED 15 31 103
19Q LOSS WILD-TYPE 108 68 34

Figure S25.  Get High-res Image Gene #74: '19q loss' versus Clinical Feature #5: 'HISTOLOGICAL.TYPE'

Methods & Data
Input
  • Copy number data file = transformed.cor.cli.txt

  • Clinical data file = LGG-TP.merged_data.txt

  • Number of patients = 359

  • Number of significantly arm-level cnvs = 78

  • Number of selected clinical features = 6

  • Exclude regions that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Student's t-test analysis

For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[3] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[4] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)